LAAO vs. Anticoagulation for Atrial Fibrillation
Presenter
Megan Coylewright, M.D., FSCAI, Erlanger Health System, Chattanooga, TN
Megan Coylewright, M.D., FSCAI, Erlanger Health System, Chattanooga, TN
Learning Objectives:
- Review evidence and indications for LAA Closure
- Identify criteria for selection of optimal management for stroke risk
- Identify patients who are not candidates for either anticoagulation and LAAO Device
Keywords: Structural Heart Disease (SHD)